跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CINNARON TABLETS 25MG - HSA Drug Approval Details
Approvals
/
HSA
/
CINNARON TABLETS 25MG
Approved
THERAPEUTIC
CINNARON TABLETS 25MG
REMEDICA LTD (CYPRUS)
🇸🇬 Health Sciences Authority
Approval Date
May 22, 1989
Approval ID
c0a1567e3ca45862
Company
REMEDICA LTD (CYPRUS)
Type
Therapeutic
Approval Details
Approval Id
c0a1567e3ca45862
Drug Name
CINNARON TABLETS 25MG
Product Name
CINNARON TABLETS 25MG
Approval Number
SIN02924P
Approval Date
1989-05-22
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N07CA02
Atc Item Name
cinnarizine
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Active Ingredients
CINNARIZINE
25 mg
CINNARIZINE
25 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 22, 1989
Approval ID
c0a1567e3ca45862
Type
Therapeutic
Back to HSA Approvals